연속 혈당 모니터링 기기 시장 : 구성 요소별, 최종사용자별, 지역별

Continuous Glucose Monitoring Devices Market is estimated to be valued at USD 8.60 Bn in 2026 and is expected to reach USD 16.86 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.

Continuous glucose monitor (CGM) is a medical device used by people with diabetes to monitor blood sugar (glucose) on a continual basis, e.g. people with type I, type II diabetes, or other types of diabetes (e.g. gestational diabetes). Thus, with the increasing prevalence of diabetes across the globe, the demand for CGM devices is also increasing rapidly, worldwide.

Market Dynamics

Increasing prevalence of diabetes, growing geriatric population, increasing demand for continuous glucose monitors (CGM), increasing adoption of technologically advanced devices, and increasing awareness among people across the globe are major factors expected to augment the growth of thelobal continuous glucose monitoring devices market.

For instance, in May 2023, Health tech company, January AI, introduced a new generative artificial intelligence (AI)-enabled app to estimate and predict the glucose response of individuals to more than 32 Bn food items. The tool requires users to wear a CGM only once and it can function even if members are not using a CGM. The platform is designed to provide users with information such as glucose estimates, predictions and key insights on an ongoing basis. Users also receive insights on increasing fibre consumption, calorie recommendations, intermittent fasting, lowering glucose-spiking foods, and getting post-meal walks.

Key features of the study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global continuous glucose monitoring devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Medtronic, Dexcom, Inc., Abbott, Novo Nordisk A/S, Ypsomed, GlySens Incorporated, and F. Hoffmann-La Roche Ltd., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global continuous glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global continuous glucose monitoring device market.

Market Segmentation

• Global Continuous Glucose Monitoring Devices Market, By Component (Revenue, USD Bn, 2021 - 2033)
• Sensors
• Transmitters
• Receivers
• Global Continuous Glucose Monitoring Devices Market, By End User (Revenue, USD Bn, 2021 - 2033)
• Hospitals
• Home care
• Others
• Global Continuous Glucose Monitoring Devices Market, By Geography (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Company Profiles
• Medtronic
• Dexcom, Inc.
• Abbott
• Novo Nordisk A/S
• Ypsomed
• GlySens Incorporated
• Hoffmann-La Roche Ltd.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Component
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing prevalence of diabetes around the world
  • High cost of continuous glucose monitors
  • Increasing demand for continuous glucose monitors
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Continuous Glucose Monitoring Devices Market, By Component, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Sensors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Transmitters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Receivers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Continuous Glucose Monitoring Devices Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Home care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Continuous Glucose Monitoring Devices Market, By Region, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

7. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dexcom, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novo Nordisk A/S
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ypsomed
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlySens Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

8. Section

• Research Methodology
• About us